| Literature DB >> 35898935 |
Jing Luo1, Liang Zhang2, Fujun Shen2, Li Luo2, Lei Chen1, Zhenxin Fan1, Rong Hou2, Bisong Yue1, Xiuyue Zhang1.
Abstract
The red panda is an endangered forest species distributed on the edge of the Qinghai Tibet Plateau. The species has been conserved in ex-situ in many countries and its survival is threatened by many diseases. Its immune system is vulnerable to age-associated alterations, which accumulate and result in a progressive deterioration that leads to an increased incidence of diseases. We identified 2,219 differentially expressed genes (DEGs) between geriatric (11-16 years) and adult individuals (4-8 years), and 1690 DEGs between adults and juveniles (1 year). The gene expression and functional annotation results showed that the innate immunity of red pandas increases significantly in geriatric individuals, whereas its change remains unclear when comparing adults and juveniles. We found that the adaptive immunity of red pandas first increased and then decreased with age. We identified CXCR3, BLNK, and CCR4 as the hub genes in the age-related protein-protein interaction network, which showed their central role in age-related immune changes. Many DNA repair genes were down-regulated in geriatric red pandas, suggesting that the DNA repair ability of the blood tissue in geriatric red pandas is significantly reduced. The significantly up-regulated TLR5 in geriatric individuals also suggests the possibility of enhancing the vaccination immune response by incorporating flagellin, which could be used to address decreased vaccine responses caused by age-related declines in immune system function. This work provides an insight into gene expression changes associated with aging and paves the way for effective disease prevention and treatment strategies for red pandas in the future. ©2022 Luo et al.Entities:
Keywords: Aging; Disease prevention; Immune alternations; Red panda; Transcriptome
Year: 2022 PMID: 35898935 PMCID: PMC9310792 DOI: 10.7717/peerj.13743
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 3.061
Figure 1Differentially expressed genes.
(A) Volcano plot between geriatric and adults showing the distribution of gene expression plotted against log2 fold change for each gene. Purple and blue dots indicate differentially expressed genes (FDR ≤ 0.05), black dots indicate non-differentially expressed genes. (B) Volcano plot between adults and juveniles. (C) Principal component analysis (PCA) of gene expression between 12 samples. (D) The comparative distribution of 563 common DEGs.
Figure 2Chord diagram of categories of immune DEGs between geriatric and adults.
Figure 3Chord diagram of categories of immune DEGs between adults and juveniles.
Figure 4Cluster analysis of Mfuzz transcriptome expression pattern.
Trend analysis clusters genes with similar expression patterns according to their temporal profiles (juvenile, adult, geriatric). GO enrichment analysis for each cluster is shown in Table S7.
Thirty-three immune-related DEGs that were common in the two comparisons.
| Gene symbol | Gene description | Log2FC | Type | |
|---|---|---|---|---|
| Adult-juvenile | Geriatric-adult | |||
|
| heat shock protein family A (Hsp70) member 1A | −4.65605793 | 2.267117457 | Antigen Processing and Presentation |
|
| complement C8 gamma chain | −1.323993749 | 1.208984757 | Antimicrobials |
|
| claudin 4 | −2.239129897 | 3.148813288 | Antimicrobials |
|
| JunD proto-oncogene, AP-1 transcription factor subunit | −1.439104566 | 1.564296492 | Antimicrobials |
|
| lipocalin 2 | −1.076628541 | 2.11372877 | Antimicrobials |
|
| NLR family member X1 | −1.035408556 | 1.164222236 | Antimicrobials |
|
| S100 calcium binding protein A7A | −1.958883689 | 2.373999596 | Antimicrobials |
|
| solute carrier family 11 member 1 | −1.115382804 | 1.968902512 | Antimicrobials |
|
| B cell linker | −1.406416584 | −1.1307455 | BCR Signaling Pathway |
|
| CD72 molecule | −1.088614858 | −1.733981295 | BCR Signaling Pathway |
|
| immunoglobulin heavy constant epsilon | 2.954148316 | −2.377432397 | BCR Signaling Pathway |
|
| leukocyte immunoglobulin like receptor B3 | −2.243575969 | 3.25109424 | BCR Signaling Pathway |
|
| apelin receptor | −4.326781357 | 4.650156681 | Cytokine Receptors |
|
| C-C motif chemokine receptor 4 | 1.644823712 | −1.052058544 | Cytokine Receptors |
|
| C-X3-C motif chemokine receptor 1 | 1.713708318 | −1.672821717 | Cytokine Receptors |
|
| 1.303070848 | 1.105685341 | Cytokine Receptors | |
|
| fibroblast growth factor receptor 3 | −1.728045213 | 2.931152467 | Cytokine Receptors |
|
| interleukin 4 receptor | −1.242601623 | 1.226363294 | Cytokine Receptors |
|
| interleukin 6 receptor | −1.172252092 | 1.423821312 | Cytokine Receptors |
|
| plexin A2 | −1.903555435 | −3.668139961 | Cytokine Receptors |
|
| retinoid X receptor alpha | −1.330663396 | 1.262262761 | Cytokine Receptors |
|
| TNF receptor superfamily member 11a | −1.335786001 | 2.560094347 | Cytokine Receptors |
|
| bone morphogenetic protein 3 | 3.739604433 | 3.60074447 | cytokines |
|
| cathelicidin antimicrobial peptide | −2.321472105 | 2.036598684 | cytokines |
|
| granulin precursor | −1.004731552 | 1.655891229 | cytokines |
|
| heparin binding growth factor | −1.302057881 | 1.944179971 | cytokines |
|
| oxidative stress induced growth inhibitor 1 | −1.367947542 | 2.399301935 | cytokines |
|
| oncostatin M | −1.292596566 | 1.396710988 | cytokines |
|
| prokineticin 2 | −1.174311847 | 2.229834977 | cytokines |
|
| semaphorin 4B | −1.066977692 | 1.364958783 | cytokines |
|
| killer cell lectin like receptor C1 | 3.806902216 | 3.528593103 | Natural Killer Cell |
|
| p21 (RAC1) activated kinase 4 | −1.430913333 | 1.28321432 | TCR Signaling Pathway |
|
| vav guanine nucleotide exchange factor 3 | −1.035902369 | 1.208782905 | TCR Signaling Pathway |